Ceramic-on-Ceramic Versus Ceramic-on-HXLPE THA

Status Completed

Clinical Trial Summary

Methods to reduce the revision rate of total hip arthroplasties (THAs) because of wear-related issues are important to examine, particularly because younger patients have a disproportionately high risk of revision. The investigators hoped to follow up patients and see if long-term Harris hip scores and WOMAC scores better in younger patients with a ceramic-on-ceramic (COC) THA compared with those with a ceramic-on-highly-cross-linked polyethylene (COP) THA.

Clinical Trial Description

High success rates obtained in the general population have stimulated for total hip arthroplasty (THA) in young and active patients. Although there have been substantial improvements in THA, bearing surface wear and osteolysis are major factors limiting the durability of THAs in young and active patients. During the last decade, alternative bearings have been developed, including highly cross-linked polyethylene (HXLPE) and ceramic-on-ceramic (COC) bearings, with the potential to reduce wear and osteolysis in younger, more active patients.

Despite contemporary cementless THA with COC bearings giving excellent clinical and radiographic outcomes, there is concern about squeaking, fracture of the ceramic head or acetabular insert or fretting and corrosion (trunnionosis). Although HXLPE have been reported to reduce polyethylene wear, there is concerned about a potential decrease in toughness, tensile strength and resistance to the propagation of fatigue cracks in a long-term follow-up.

Several noncomparative studies of COC and COP THA have reported promising results in terms of Harris hip scores, radiographic findings, and survival rates, yet we are aware of no long-term comparative clinical studies with a COC THA and a COP THA in the same younger patients. This study aimed to see if long-term Harris hip scores and Western Ontario and McMaster Universities Osteoarthritis (WOMAC) score better in younger patients with a COC THA compared with those with a COP THA. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03639532
Study type	Interventional
Source	Ewha Womans University
Contact
Status	Completed
Phase	Phase 4
Start date	January 1, 2000
Completion date	May 31, 2018

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05773261` - Clinical Investigation Comparing Two Different Ultra-porous Coated Surfaces of Uncemented Cups	N/A
Recruiting	`NCT05223777` - KINCISE™ Surgical Automated System in Total Hip Arthroplasty (THA)	N/A
Recruiting	`NCT04731077` - Avenir Complete Post-Market Clinical Follow-Up Study	N/A
Not yet recruiting	`NCT04448106` - Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis	Phase 2
Completed	`NCT05070871` - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women	N/A
Not yet recruiting	`NCT06162195` - The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement	N/A
Withdrawn	`NCT02743208` - Evaluation of a Short Femoral Stem in Total Hip Arthroplasty	N/A
Completed	`NCT02944448` - A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee	Phase 2
Active, not recruiting	`NCT02229279` - Evaluation of Teleconsulting on Rehabilitation After Hip and Knee Surgical Procedures	N/A
Active, not recruiting	`NCT02851992` - A Prospective Study to Evaluate Long-term Clinical Outcomes of the GTS Cementless Femoral Stem	N/A
Completed	`NCT01700933` - Dose-response: Exercise Therapy on Hip Osteoarthritis	N/A
Completed	`NCT01618708` - A Study of the Safety and Effectiveness of Synvisc-One® (Hylan G-F 20) in Patients With Primary Osteoarthritis of the Hip	N/A
Completed	`NCT01214954` - Early Rehabilitation After Total Hip Replacement	N/A
Active, not recruiting	`NCT00294424` - Study on Costs and Effects of Waiting Time in Total Hip and Knee Replacements	N/A
Terminated	`NCT00588861` - Total Hip Replacement With the Answer® Hip Stem and Ranawat/Burnstein® Shell Using Simplex® or Palacos® Bone Cement	N/A
Withdrawn	`NCT05054595` - Audio-Recorded vs. Nurse-Led Brief Mindfulness-Based Intervention	N/A
Terminated	`NCT00973141` - A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain	Phase 2
Recruiting	`NCT05014113` - H-28 DELTA ST-C and Minima Retrospective Study.
Completed	`NCT01066936` - Mini Stem DEXA (Dual Energy X-ray Absorptiometry)
Recruiting	`NCT06185036` - Histological Validation of dGEMRIC Indices as a Quantitative Biomarker for Cartilage Damage in the Hip Joint

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.